Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
53.70 EUR | +3.27% | +6.76% | -4.79% |
Dec. 09 | Formycon Enters Commercialization Deal for Stelara Biosimilar in Middle East, North Africa | MT |
Dec. 05 | German Stocks Shrug Off Worsening Construction Slump | MT |
Chart calendar Formycon AG
Upcoming events on Formycon AG
Past events on Formycon AG
2024-12-01 | H.C. Wainwright Virtual Fireside Chat Conference |
2024-11-28 09:00 am | Q3 2024 Earnings Call |
2024-11-27 | Q3 2024 Earnings Release |
2024-11-24 | German Equity Forum |
2024-11-18 | Jefferies London Healthcare Conference |
2024-11-04 | Berenberg Virtual Fireside Chat Conference |
2024-09-22 | Berenberg and Goldman Sachs German Corporate Conference |
2024-09-18 | Pareto Securities Healthcare Conference |
2024-09-08 | H.C. Wainwright Global Investment Conference |
2024-08-13 09:00 am | Q2 2024 Earnings Call |
2024-08-12 | Q2 2024 Earnings Release |
2024-06-11 | Annual General Meeting |
2024-05-20 | Berenberg European Conference |
2024-05-14 | Hauck Aufhäuser Stockpicker Summit |
2024-05-12 | German Spring Conference |
2024-05-08 09:00 am | Q1 2024 Earnings Call |
2024-05-07 | Q1 2024 Earnings Release |
2024-04-25 09:00 am | Q4 2023 Earnings Call |
2024-04-24 | Q4 2023 Earnings Release |
2024-04-21 | Metzler Small Cap Day |
Annual results
Fiscal Period | December | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 37,0 40,9 -9.55% | 42,5 43,0 -1.17% | 77,7 77,7 0.04% | 60,3 | 90,8 | 179 |
EBITDA Million EUR | Released Forecast Spread | -12,4 -11,6 -7.11% | -15,9 -21,9 27.39% | 1,52 1,00 51.8% | -20,9 | 11,4 | 97,4 |
EBIT Million EUR | Released Forecast Spread | -13,3 -12,6 -5.64% | -17,7 -23,3 23.91% | -0,37 -6,00 93.85% | -24,3 | -3,14 | 93,0 |
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -13,5 -12,7 -5.79% | 36,6 -23,4 256.73% | 79,1 73,0 8.32% | -8,62 | 10,8 | 113 |
Net income Million EUR | Released Forecast Spread | -13,5 -12,7 -5.94% | 36,0 17,7 103.92% | 75,8 75,9 -0.14% | -10,6 | 10,4 | 93,2 |
EPS EUR | Released Forecast Spread | -1,22 -1,19 -2.63% | 2,59 1,21 114.05% | 4,72 0,00 - | -0,55 | 0,56 | 4,81 |
Announcement Date | 18/05/22 | 27/04/23 | 25/04/24 | - |
Quarterly results
Fiscal Period | June | 2023 S1 | 2024 Q2 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 |
---|---|---|---|---|---|---|---|---|
Net sales Million EUR | Released Forecast Spread | 9,19 14,0 -34.34% | 18,0 | 18,0 | 19,0 | 30,0 | 38,0 | |
EBIT Million EUR | Released Forecast Spread | -5,40 | -4,04 | |||||
Earnings before Tax (EBT) Million EUR | Released Forecast Spread | -4,95 | 0,46 | |||||
Net income Million EUR | Released Forecast Spread | 1,80 -3,31 154.47% | -4,95 | 0,46 | ||||
EPS EUR | Released Forecast Spread | 0,11 -0,20 156.5% | -0,29 | 0,03 | 0,00 | 0,01 | 0,19 | 0,31 |
Announcement Date | 30/08/23 | 13/08/24 | - | - | - | - | - |
Past sector events for Formycon AG
2024-11-27 | FORMYCON AG: Q3 2024 Earnings Release |
2024-11-20 07:00 am | SEPTERNA, INC.: Q3 2024 Earnings Release |
2024-11-20 02:00 am | GENUS PLC: Q1 2025 Sales and Revenue Release - Trading Update |
2024-11-19 | MESOBLAST LIMITED: Q1 2025 Earnings Release (Projected) |
2024-11-14 08:00 am | ARRIVENT BIOPHARMA, INC.: Q3 2024 Earnings Release |
2024-11-14 08:00 am | SILENCE THERAPEUTICS PLC: Q3 2024 Earnings Release |
2024-11-14 02:00 am | BIOARCTIC AB: Q3 2024 Earnings Release |
2024-11-13 | VORONOI, INC.: Q3 2024 Earnings Release |
2024-11-13 | GNI GROUP LTD.: Q3 2024 Earnings Release |
2024-11-13 04:10 pm | PHARVARIS N.V.: Q3 2024 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- FYB Stock
- Calendar Formycon AG